- PARADIGM ™ program comprises two 12-week randomized, placebo-controlled studies (APPROACH and EMBRACE) and a long-term extension study (EXTEND) - - EXTEND: a Phase III Open Label Extension Study ...
Nursing instructor Mary Iverson liked to speak Spanish, to socialize, sew. Yet in her late 50s, Mary, wife of cardio-thoracic surgeon Leigh Iverson, and mother to their three daughters, noticed ...
“Just three years after filing an Investigational New Drug application for CYB003, the initiation of our Phase 3 program is a truly significant and gratifying milestone,” said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results